Genes Related to Vascular Disease (APOE, VLDL-R, DCP-1) and Other Vascular Factors in Late-Life Depression

American Journal of Geriatric Psychiatry

Volumn 12, Issue 2, 2004, Pages 202-210

  Cervilla, Jorge A ^a,c   Prince, Martin ^a   Joels, Suzanne ^b   Russ, Carsten ^a   Lovestone, Simon ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b ROYAL FREE HOSPITAL   (United Kingdom)

^c PARC SANITARI SANT JOAN DE DÉU   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; APOLIPOPROTEIN E; DIPEPTIDYL CARBOXYPEPTIDASE; NONSTEROID ANTIINFLAMMATORY AGENT; VERY LOW DENSITY LIPOPROTEIN RECEPTOR;

ADULT; AGED; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; COGNITION; DEPRESSION; DIASTOLIC BLOOD PRESSURE; DNA POLYMORPHISM; FEMALE; GENDER; GENETIC ANALYSIS; GENETIC VARIABILITY; GENOTYPE; GERONTOPSYCHIATRY; HEART ARRHYTHMIA; HUMAN; ISCHEMIA; MAJOR CLINICAL STUDY; MALE; RISK FACTOR; SMOKING; SYSTOLIC BLOOD PRESSURE; VASCULITIS;

EID: 1342322895     PISSN: 10647481     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019442-200403000-00011     Document Type: Article

References (54)

1. Pohjasvaara T, Leppavuori A, Siira I, et al: Frequency and clinical determinants of post-stroke depression. Stroke 1998; 29:2311-2317
2. Gainotti G, Azzoni A, Marra C: Frequency, phenomenology, and anatomo-clinical correlates of major post-stroke depression. Br J Psychiatry 1999; 175:163-167
3. Sultzer DL, Levin HS, Mahler ME, et al: A comparison of psychiatric symptoms in vascular dementia and Alzheimer's disease. Am J Psychiatry 1993, 150:1806-1812
4. O'Brien J, Ames D, Schweitzer I, et al: White-matter changes in depression and Alzheimer's disease: a review of magnetic resonance imaging studies. Int J Geriatr Psychiatry 1996; 11:681-694
5. De Groot JC, de Leeuw F, Oudkerk M, et al: Cerebral white-matter lesions and depressive symptoms in elderly adults. Arch Gen Psychiatry 2000; 57:1071-1076
6. González MB, Snyderman TB, Colket JK, et al: Depression in patients with coronary artery disease. Depression 1996; 4:57-62
7. Kendler KS, Neale MC, MacLean CJ, et al: Smoking and major depression: a causal analysis. Arch Gen Psychiatry 1993; 50:36-43
8. Schleifer SJ, Macari-Hinson MM, Coyle DA, et al: The nature and course of depression following myocardial infarction. Arch Intern Med 1989; 149:1785-1789
9. Rabkin JG, Charles E, Kass F: Hypertension and DSM-III depression in psychiatric outpatients. Am J Psychiatry 1983; 140:1072-1074
10. Taylor WD, Payne ME, Krishnan KRR, et al: Evidence of white-matter tract disruption in MRI hyperintensities. Biol Psychiatry 2001; 50:179-183
11. Stewart R: Interface between cerebrovascular disease, depression, and dementia, in Vascular Disease and Affective Disorders. Edited by Chiu E, Ames D, Katona C. London, UK, Martín Dunitz, 2002, pp 189-202
12. Prince M, Harwood R, Thomas A, et al: A prospective, population-based cohort study of the effects of disablement and social milieu on the onset and maintenance of late-life depression. The Gospel Oak Project, VII. Psychol Med 1998; 28:337-350
13. Mann AH: Psychological Factors in Hypertension and the Impact of its Diagnosis. Psychol Med Monograph 1984, suppl. 5
14. Davignon J, Cohn JS, Mabile L, et al: Apolipoprotein-E and atherosclerosis: insight from animal and human studies. Clinica Chimica Acta 1999; 286:115-143
15. Hoffman A, Ott A, Breteler MM, et al: Atherosclerosis, apolipoprotein-E, and prevalence of dementia and Alzheimer's disease. Lancet 1997, 349:151-154
16. Rigaud AS, Traykov L, Caputo L, et al: Association of the apolipoprotein-E epsilon-4 allele with late-onset depression. Neuroepidemiology 2001; 20:4:268-272
17. Schmand B, Hooijer C, Jonker C, et al: Apolipoprotein-E phenotype is not related to late-life depression in a population-based sample. Soc Psychiatry Psychiatr Epidemiol 1998; 33:21-26
18. Holmes C, Russ C, Kirov G, et al: Apolipoprotein-E: depressive illness, depressive symptoms, and Alzheimer's disease. Biol Psychiatry 1998; 43:159-164
19. Helbecque N, Berr C, Cottel D, et al: VLDL receptor polymorphism, cognitive impairment, and dementia. Neurology 2001; 56:1183-1188
20. Tacken PJ, Delsing DJM, Gijbels MJJ, et al: VLDL receptor deficiency enhances intimal thickening after vascular injury but does not affect atherosclerotic lesion area. Atherosclerosis 2002; 162:103-110
21. Okuizumi K, Onodera O, Namba Y, et al: Genetic association of the very low density lipoprotein (VLDL) receptor gene with sporadic Alzheimer's disease. Nature Genet 1995; 11:207-209
22. Sagnella GA, Rothwell MJ, Onipinla AK, et al: A population study of ethnic variations in the angiotensin-converting enzyme I/D polymorphism: relationships with gender, hypertension, and impaired glucose metabolism. J Hypertens 1999; 17:657-664
23. Kennon B, Petrie JR, Small M, et al: Angiotensin-converting enzyme gene and diabetes mellitus. Diabet Med 1999; 16:448-458
24. Cambien F, Poirier O, Lecerf L, et al: Deletion polymorphism at the angiotensin-converting enzyme gene is a potent risk factor for myocardial infarction. Nature 1992; 359:641-644
25. Raynolds MV, Bristow MR, Bush EW, et al: Angiotensin-converter enzyme DD genotype in patients with ischemic or idiopathic dilated cardiomyopathy. Lancet 1993; 342:1073-1075
26. Kehoe PG, Russ C, McIlroy S, et al: Variation in DCP-1-encoding ACE is associated with susceptibility to Alzheimer disease. Nature Genet 1999; 21:71-72
27. MRC Working Party: MRC Research Council Trial of Treatment of Hypertension in Older Adults: principal results. BMJ 1992; 304:405-412
28. Cervilla JA, Prince M, Joels S, et al: Long-term determinants of cognitive outcome in a cohort of elderly hypertensives. Br J Psychiatry 2000a; 177:66-71
29. Bird AS, Blizard R, Mann A: Treating hypertension in the older person: an evaluation of the association of blood pressure level and its reduction with cognitive performance. J Hypertens 1990; 8:147-152
30. Prince MJ, Lewis G, Bird A, et al: A longitudinal study of factors predicting change in cognitive test scores over time in an older hypertensive population. Psychol Med 1996; 26:555-568
31. Prince M, Cullen MC, Mann A: Risk factors for Alzheimer's disease and dementia: a case-control study based on the MRC Elderly Hypertension Trial. Neurology 1994; 44:97-104
32. Bird A, MacDonald A, Mann AH, et al: Preliminary experience with the Self-Care (D): a self-rating depression questionnaire for use in elderly, non-institutionalized subjects. Int J Geriatr Psychiatry 1987; 2:31-38
33. Gurland B, Kuriansky J, Sharpe L, et al: The comprehensive assessment of referral evaluation (CARE) rationale: development and reliability. Int J Ageing Hum Devel 1977; 8:9-42
34. Copeland J, Dewey M, Griffiths-Jones H: Computerised psychiatric diagnostic system and case nomenclature for elderly subjects: GMS and AGECAT. Psychol Med 1986; 16:89-99
35. Banerjee S, Shamah K, MacDonald A, et al: The use of the Self-Care (D) as a screening tool for depression in the clients of local authority home-care services: a preliminary study. Int J Geriatr Psychiatry 1998; 13:695-699
36. Inglis J: A paired-associate learning test for use with elderly psychiatric patients. Journal of Mental Science 1959; 105:440-443
37. Reltan RM: Validity of the Trail-Making Test as an indication of organic brain damage. Percept Mot Skills 1959; 8:271-276
38. Raven JC: Matrix tests. Mental Health 1940; 1:10-18
39. Wenham PR, Price WH, Blundell G: Apolipoprotein-Egenotyping by one-stage PCR. Lancet 1991; 337:1158-1159
40. Prince M, Lovestone S, Cervilla JA, et al: The association between APOE and dementia is mediated neither by vascular disease nor its risk factors in an aged cohort of survivors. Neurology 2000; 54:397-402
41. Cantillon M, Harwood D, Barker W: No association between apolipoprotein-E genotype and late-onset depression in Alzheimer's disease. Biol Psychiatry 1997; 41:246-248
42. Kessing LV, Jorgensen OS: Apolipoprotein-E-epsilon-4 frequency in affective disorder. Biol Psychiatry 1999; 45:430-434
43. Stewart R, Russ C, Richards M, et al: Depression, APOE genotype, and subjective memory impairment: a cross-sectional study in an African-Caribbean population. Psychol Med 2001; 31:431-440
44. Alexopoulos G: New concepts for prevention and treatment of late-life depression. Am J Psychiatry 2001; 158:835-838
45. Krishnan KR, Hays JC, Blazer D: MRI-defined vascular depression. Am J Psychiatry 1997; 154:497-501
46. Pauls J, Bandelow B, Ruther E, et al: Polymorphism of the gene of angiotensin-converting enzyme: lack of association with mood disorder. J Neural Trans 2000; 107:1361-1366
47. Segman RH, Shapira Y, Modai I, et al: Angiotensin-converting enzyme gene insertion/deletion polymorphism: case-control association studies in schizophrenia, major affective disorder, and tardive dyskinesia and a family-based association study in schizophrenia. Am J Med Genet 2002; 114:310-314
48. Chen T, Ganguli M, Mulsant B, et al: The temporal relationship between depressive symptoms and dementia: a community prospective study. Arch Gen Psychiatry 1999; 56:251-266
49. Cervilla JA, Prince M, Joels S, et al: Does depression predict cognitive function 9 to 12 years earlier?: evidence from a longitudinal study of elderly, community-dwelling volunteers. Psychol Med 2000b; 30:1017-1023
50. Fava M, Abraham M, Pava J, et al: Cardiovascular risk factors in depression: the role of anxiety and anger. Psychosomatics 1996; 37:31-37
51. Paterniti S, Verdier-Taillefer M, Geneste C, et al: Low blood pressure and risk of depression in the elderly: a prospective, community-based study. Br J Psychiatry 2000; 176:464-467
52. Dierker L, Avenevoli S, Stolar M, et al: Smoking and depression: an examination of mechanisms of comorbidity. Am J Psychiatry 2002; 159:947-953
53. Ockene J, Benfari R, Hurwitz I, et al: Relationship of psychosocial factors to smoking behaviour change in an intervention program. Prev Med 1982; 11:13-28
54. Percival C, Creed F, Dickens C, et al: Social stress and depression in myocardial infarction patients. J Psychosom Res 2000; 48:106